References
- Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States 1973-2002. JAMA. 2006; 295(18): 2164-2167.
- Akulevich NM, Saenko VA, Rogounovitch TI, Drozd VM, Lushnikov EF, Ivanov VK, et al. Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma. Endocr Relat Cancer. 2009; 16(2): 491-503.
- Lence-Anta JJ, Xhaard C, Ortiz RM, Kassim H, Pereda CM, Turcios S, et al. Environmental, lifestyle, and anthropometric riskfactors for differentiated thyroid cancer in cuba: a case-control study. Eur Thyroid J. 2014; 3(3): 189-196.
- Bashir K, Sarwar R, Fatima S, Saeed S, Mahjabeen I, Akhtar Kayani M. Haplotype analysis of XRCC1 gene polymorphisms and the risk of thyroid carcinoma. J BUON. 2018; 23(1): 234-243.
- Matsuse M, Mitsutake N, Tanimura S, Ogi T, Nishihara E, Hirokawa M, et al. Functional characterization of the novel BRAF complexmutation, BRAF (V600 delinsYM), identified in papillarythyroid carcinoma. Int J Cancer. 2013; 132(3): 738-743.
- Hu Z, Hu X, Long J, Su L, Wei B. XRCC1 polymorphisms and differentiated thyroid carcinoma risk: A meta-analysis. Gene. 2013; 528(2): 67-73.
- Du Y, Han LY, Li DD, Liu H, Gao YH, Sun D. Associations between XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms and risk of differentiated thyroid carcinoma: A meta-analysis. Asian Pac J Cancer Prev. 2013; 14(9): 5483-5487.
- Chang-Claud J, Popanda O, Tan XL, Kropp S, Helmbold I, von Fournier D, et al. Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Clin Cancer Res. 2005; 11(13): 4802-4809.
- Zhai W, Feng R, Wang H, Wang Y. Note of clarification of data in the papertitled X-ray repair cross-complementing group 1 codon 399 polymorphism and lung cancer risk: An updated meta-analysis. Tumour Biol. 2015; 36(5): 3179-3189.
- Bu T, Liu L, Sun Y, Zhao L, Peng Y, Zhou S, et al. XRCC1 Arg399Gln polymorphism confers risk of breast cancer in American population: A meta-analysis of 10846 cases and 11723 controls. PLoS One. 2014; 9(1): e86086.
- Tian Z, Li YL, Liu JG. XRCC1 Arg399Gln polymorphism contributes to increased risk of colorectal cancer in Chinese population. Mol Biol Rep. 2013; 40(7): 4147-4151.
- Ho T, Li G, Lu J, Zhao C, Wei Q, Sturgis EM. Association of XRCC1 polymorphisms and risk of differentiated thyroid carcinoma: A case-control analysis. Thyroid. 2009; 19(2): 129-135.
- Chiang FY, Wu CW, Hsiao PJ, Kuo WR, Lee KW, Lin LC, et al. Association between polymorphisms in DNA base excision repair genes XRCC1, APE1, and ADPRT and differentiated thyroid carcinoma. Clin Cancer Res. 2008; 14(18): 5919-5924.
- Garcia-Quispes WA, Perez-Machado G, Akdi A, Pastor S, Galofre P, Biarnes F, et al. Association studies of OGG1, XRCC1, XRCC2 and XRCC3 polymorphisms with differentiated thyroid cancer. Mutat Res. 2011: 709-710: 67-72.
- Zhu QX, Bian JC, Shen Q, Pastor S, Galofré P, Zhang HW, et al. Genetic polymorphisms in X-ray repair cross-complementing gene 1 and susceptibility to papillary thyroid carcinoma. Zhonghua Liu Xing Bing Xue Za Zhi. 2004; 25(8): 702-705.
- Ryu RA, Tae K, Min HJ, Jeong JH, Cho SH, Lee SH, et al. XRCC1 polymorphisms and risk of papillary thyroid carcinoma in a Korean sample. J Korean Med Sci. 2011; 26(8): 991-995.
- Zhu J, Qi P, Li Z. Interaction between XRCC1 gene polymorphisms and obesity on susceptibility to papillary thyroid cancer in Chinese Han population. Cell Physiol Biochem. 2018; 49(2): 638-644.
- Sigurdson AJ, Land CE, Bhatti P, Pineda M, Brenner A, Carr Z, et al. Thyroid nodules, polymorphic variants in DNA repair and RET-related genes, and interaction with ionizing radiation exposure from nuclear tests in Kazakhstan. Radiat Res. 2009; 171(1): 77-88.
- Wang X, Zhang K, Liu X, Liu B, Wang Z. Association between XRCC1 and XRCC3 gene polymorphisms and risk of thyroid cancer. Int J Clin Exp Pathol. 2015; 8(3): 3160-3167.
- Wang C, Ai Z. Association of XRCC1 polymorphisms with thyroid cancer risk. Tumour Biol. 2014;35:4791-7.
- Yan L, Li Q, Li X, Ji H, Zhang L. Association studies between XRCC1, XRCC2, XRCC3 polymorphisms and differentiated thyroid carcinoma. Cell Physiol Biochem. 2016; 38(3): 1075-1084.
- Fan J, Otterlei M, Wong HK, Tomkinson AE, Wilson DM 3rd. XRCC1 co-localizes and physically interacts with PCNA. Nucleic Acid Res. 2004; 32(7): 21932201.
- Caldecott KW. XRCC1 and DNA strand repair. DNA Repair (Amst). 2003; 2(9): 955-969.
- Hung RJ, Hall J, Brennan P, Boffetta P. Genetic polymorphism in the base excision repair pathway and cancer risk. A HuGE review. Am J Epidemiol. 2005; 162(10): 925-942.
- Yan L, Yanan D, Donglan S, Na W, Rongmiao Z, Zhifeng C. Polymorphisms of XRCC1 gene and risk of gastric cardiac adenocarcinoma. Dis Esophagus. 2009; 22(5): 396-401.
- Takanami T, Nakamura J, Kubota Y, Horiuchi S. The Arg280His polymorphism in X-ray repair cross-complementing gene 1 impairs DNA repairability. Mutat Res. 2005; 582(1-2): 135-145.
- Zhang K, Zhou B, Wang Y, Rao L, Zhang L. The XRCC1 Arg280His polymorphism contributes to cancer susceptibility: An update by meta-analysis of 53 individual studies. Gene. 2012; 510(2): 93-101.
- Qian K, Liu KJ, Xu F, Chen XY, Chen GN, Yi WJ, et al. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and thyroid carcinoma risk: A meta-analysis. Asian Pac J Cancer Prev. 2012; 13(12): 6385-6390.
- Yang D, Han L-Y, Li D-D, Liu H, Gao YH, Sun DJ. Associations between XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms and risk of differentiated thyroid carcinoma: A meta-analysis. Asian Pac J Cancer Prev. 2013; 14(9): 5483-5487.
- Hu Z, Hu X, Long J, Su L, Wei B. XRCC1 poly-morphisms and differentiated thyroid carcinoma risk: A meta-analysis. Gene. 2013; 528(2): 67-73.
- Bao Y, Jiang L, Zhou JY, Zou JJ, Zheng JY, Chen XF, et al. XRCC1 gene polymorphisms and the risk of differentiated thyroid carcinoma (DTC): A meta-analysis of case-control studies. PLos One. 2013; 8(5): e64851.
- Wang C, Ai Z. Association of XRCC1 polymorphisms with thyroid cancer risk. Tumor Biol. 2014; 35(5): 4791-4797.
- Zhou W, Liu G, Miller DP, Thurston SW, Xu LL, Wain JC, et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking and lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2003; 12(4): 359-365.
- Dailey ME, Lindsay S, Skahen R. Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland. Arch Surg. 1955; 70(2): 291-297.
- Cheema Y, Olson S, Elson D, Chen H. What is the biology and optimal treatment for papillary micro-carcinoma of the thyroid? J Surg Res. 2006; 134(2): 160-162.
- Jankovic B, Le KT, Hershman JM. Clinical Review: Hashimoto’s thyroiditis and papillary thyroid carcinoma: Is there a correlation? J Clin Endocrinol Metab. 2013; 98(2): 474-482.